Across TCGA patient cohorts, S100A7L2 mutation is significantly associated with the total protein of many other genes, with 3 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible S100A7L2-associated genes across cancer lineages are Paxillin, MSH6, and BRD4. Each is linked with S100A7L2 in more than 1 cancer types. Because this analysis shows association rather than direction, both S100A7L2-to-partner and partner-to-S100A7L2 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (S100A7L2→partner) and Y-score (partner→S100A7L2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	Paxillin →	+0.390	+2.817	.014	.036	3	1
SKCM	MSH6 →	-0.380	-3.000	.040	.036	3	1
UCEC	BRD4 →	+0.498	+2.814	.002	.036	1	1

Each partner links to its Q-omics profile. Showing the 3 strongest of 3 associations by consensus.

Exploration

S100A7L2 survival (RNA) · tumor vs normal (RNA) · all S100A7L2 data types